Background

Diabetes is an increasingly prevalent chronic disease that affects approximately 10% of the world’s population and is the 7th leading cause of death worldwide. Insulin therapy is currently the standard of care in controlling and regulating blood glucose levels in diabetes; however, current methods of administration (by subcutaneous injection) are not convenient and result in some patient populations delaying or avoiding treatment due to fear of needles and self-injection. Therefore, new methods of insulin delivery that are more convenient and non-invasive have the potential to revolutionize diabetes care by driving increased patient adoption.